# MitoImmune Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mitoimmune-therapeutics

- Industry: Biotechnology
- Headquarters: Seoul, South Korea
- Website: www.mitoimmune.com
- Total disclosed funding: $39M
- Latest round: Series B (Jul 29, 2023)
- Investors on record: 14

## About

Established in 2018 and based in Seoul, South Korea, MitoImmune Therapeutics Inc. is a drug and biotechnology development company that uses mitochondria and proprietary technologies targeting mitochondria as a source for the development of new potential breakthrough therapies. The company’s lead program is based on the breakthrough scientific findings of its founder Soon Ha Kim at LG Life Sciences which was acquired by LG Chem in the end of 2017, and exclusively in-licensed the technology from LG Chem.

The company mainly increases healthy lifespan by developing treatments for mitochondrial dysfunction-related necrosis and inflammatory diseases, and is conducting global and domestic Phase 2 clinical trials for Oral Mucositis of HNSCC patients and HSCT pre-conditioning regimen respectively, which has high unmet medical needs, and to carry out full-scale activities for global licensing deals.

## Funding rounds

- Series B, Jul 29, 2023, $4.1M — BNC Korea, K-Ground Ventures, BMIKOREA
- Series B, Feb 25, 2021, $24M — Korea Development Bank, AJU IB Investment, KB Investment, SL Investment, IMM Investment, CJ Investment, BNH Investment, KB Securities, Quantum Ventures Korea, GTO Investment, Orion Capital Management
- Series A, Apr 19, 2019, $11M — Korea Development Bank, KB Investment, SL Investment, BNH Investment

## Investors

- Korea Development Bank (https://capitalatlas.ai/funds/korea-development-bank) — Series A, Series B
- KB Investment (https://capitalatlas.ai/funds/kb-investment) — Series A, Series B
- SL Investment (https://capitalatlas.ai/funds/sl-investment) — Series A, Series B
- BNH Investment (https://capitalatlas.ai/funds/bnh-investment) — Series A, Series B
- AJU IB Investment (https://capitalatlas.ai/funds/aju-ib-investment) — Series B
- IMM Investment (https://capitalatlas.ai/funds/imm-investment) — Series B
- CJ Investment (https://capitalatlas.ai/funds/cj-investment) — Series B
- KB Securities (https://capitalatlas.ai/funds/kb-securities) — Series B
- Quantum Ventures Korea (https://capitalatlas.ai/funds/quantum-ventures-korea) — Series B
- GTO Investment (https://capitalatlas.ai/funds/gto-investment) — Series B
- Orion Capital Management (https://capitalatlas.ai/funds/orion-capital-management) — Series B
- BNC Korea — Series B
- K-Ground Ventures (https://capitalatlas.ai/funds/k-ground-ventures) — Series B
- BMIKOREA — Series B